Eugene Schneider Ionis Pharmaceuticals Inc (IONS) insider trading activity

IONS Quotes by TradingView

Eugene Schneider is EVP, Chf Clinical Develop Ofcr of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 51,507 shares of IONS, which is worth approximately $3.73 Million. The most recent transaction as insider was on Jan 15, 2021, when has been sold 2,718 shares (Common Stock) at a price of $61.28 per share, resulting in proceeds of $166,559. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51.5K
15.64% 3M change
3.4% 12M change
Total Value Held $3.73 Million

Eugene Schneider Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 15 2021
SELL
Payment of exercise price or tax liability
$166,559 $61.28 p/Share
2,718 Reduced 28.25%
6,903 Common Stock
Jan 15 2021
BUY
Exercise of conversion of derivative security
-
7,503 Added 43.82%
9,621 Common Stock
ES

Eugene Schneider

EVP, Chf Clinical Develop Ofcr
Carlsbad, CA

Track Institutional and Insider Activities on IONS

Follow IONIS PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

News

Receive news related to IONIS PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IONS